Total Payments
$964.11
2024 Payments
$58.35
Companies
17
Transactions
38
Medicare Patients
1,566
Medicare Billing
$63,753
Payment Breakdown by Category
Food & Beverage$964.11 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $964.11 | 38 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $139.13 | 4 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $107.19 | 4 | $0 (2023) |
| Endo Pharmaceuticals Inc. | $105.85 | 5 | $0 (2023) |
| Boston Scientific Corporation | $103.00 | 1 | $0 (2023) |
| Antares Pharma, Inc. | $102.32 | 6 | $0 (2023) |
| Merck Sharp & Dohme LLC | $72.93 | 3 | $0 (2023) |
| Medtronic, Inc. | $64.78 | 1 | $0 (2021) |
| Astellas Pharma US Inc | $47.38 | 3 | $0 (2023) |
| Myovant Sciences Inc. | $37.77 | 2 | $0 (2022) |
| Ambu Inc. | $35.57 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $58.35 | 2 | Ambu Inc. ($35.57) |
| 2023 | $513.02 | 18 | Bayer Healthcare Pharmaceuticals Inc. ($107.19) |
| 2022 | $246.22 | 12 | Endo Pharmaceuticals Inc. ($41.92) |
| 2021 | $146.52 | 6 | Medtronic, Inc. ($64.78) |
All Payment Transactions
38 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/21/2024 | Ambu Inc. | — | Food and Beverage | Cash or cash equivalent | $35.57 | General |
| 01/17/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $22.78 | General |
| Category: UROLOGY | ||||||
| 12/01/2023 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological), AVEED | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: UROLOGY | ||||||
| 11/01/2023 | Boston Scientific Corporation | Moses 550 D\F\L (Device) | Food and Beverage | In-kind items and services | $103.00 | General |
| Category: Moses 550 D F L_URO | ||||||
| 10/19/2023 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $28.51 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/06/2023 | Endo Pharmaceuticals Inc. | AVEED (Biological), XIAFLEX | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: UROLOGY | ||||||
| 07/12/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG, LYNPARZA | Food and Beverage | In-kind items and services | $25.16 | General |
| Category: ONCOLOGY | ||||||
| 06/27/2023 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $25.03 | General |
| Category: Oncology | ||||||
| 06/21/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Urology | ||||||
| 06/14/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $28.27 | General |
| Category: Oncology | ||||||
| 06/06/2023 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: Oncology | ||||||
| 05/02/2023 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $30.88 | General |
| Category: Oncology | ||||||
| 04/20/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $31.27 | General |
| Category: Oncology | ||||||
| 03/29/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: Urology | ||||||
| 03/15/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $24.55 | General |
| Category: ONCOLOGY | ||||||
| 03/08/2023 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $26.53 | General |
| Category: Oncology | ||||||
| 02/14/2023 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Oncology | ||||||
| 01/25/2023 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $24.75 | General |
| Category: Oncology | ||||||
| 01/23/2023 | Antares Pharma, Inc. | NOCDURNA (Drug), XYOSTED, TLANDO | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | ||||||
| 01/04/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $39.57 | General |
| Category: Oncology | ||||||
| 12/20/2022 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological), AVEED | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: UROLOGY | ||||||
| 12/07/2022 | Myovant Sciences Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: HORMONE THERAPY | ||||||
| 11/29/2022 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Oncology | ||||||
| 10/25/2022 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: ONCOLOGY | ||||||
| 10/24/2022 | Axonics, Inc. | Axonics (Device), Bulkamid | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: Urology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 867 | 1,030 | $112,648 | $34,703 |
| 2022 | 7 | 612 | 670 | $82,375 | $26,330 |
| 2021 | 4 | 87 | 87 | $7,880 | $2,719 |
Total Patients
1,566
Total Services
1,787
Medicare Billing
$63,753
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 207 | 240 | $44,230 | $12,895 | 29.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 74 | 74 | $25,126 | $7,440 | 29.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 52 | 55 | $14,414 | $4,604 | 31.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 47 | 51 | $9,436 | $3,114 | 33.0% |
| 51703 | Complicated insertion of bladder tube | Office | 2023 | 15 | 21 | $6,540 | $2,150 | 32.9% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 213 | 264 | $5,904 | $2,035 | 34.5% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 24 | 38 | $4,844 | $1,461 | 30.2% |
| 81003 | Automated urinalysis test | Office | 2023 | 210 | 259 | $817.00 | $568.00 | 69.5% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 25 | 28 | $1,337 | $436.05 | 32.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 133 | 144 | $27,504 | $8,550 | 31.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 70 | 70 | $24,500 | $7,968 | 32.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 66 | 68 | $18,428 | $5,662 | 30.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 25 | 27 | $5,184 | $1,705 | 32.9% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 149 | 168 | $3,696 | $1,385 | 37.5% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2022 | 11 | 15 | $1,995 | $666.75 | 33.4% |
| 81003 | Automated urinalysis test | Office | 2022 | 158 | 178 | $1,068 | $393.05 | 36.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 17 | 17 | $4,607 | $1,565 | 34.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 13 | 13 | $2,483 | $843.70 | 34.0% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2021 | 28 | 28 | $616.00 | $245.28 | 39.8% |
| 81003 | Automated urinalysis test | Office | 2021 | 29 | 29 | $174.00 | $65.25 | 37.5% |
About Tess Martens, APRN
Tess Martens, APRN is a Urology healthcare provider based in Wakefield, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2021. The National Provider Identifier (NPI) number assigned to this provider is 1225606247.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Tess Martens, APRN has received a total of $964.11 in payments from pharmaceutical and medical device companies, with $58.35 received in 2024. These payments were reported across 38 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($964.11).
As a Medicare-enrolled provider, Martens has provided services to 1,566 Medicare beneficiaries, totaling 1,787 services with total Medicare billing of $63,753. Data is available for 3 years (2021–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Other Specialties Family, Nurse Practitioner
- Location Wakefield, RI
- Active Since 06/15/2021
- Last Updated 07/01/2021
- Taxonomy Code 208800000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1225606247
Products in Payments
- ERLEADA (Drug) $139.13
- Nubeqa (Drug) $107.19
- Moses 550 D\F\L (Device) $103.00
- KEYTRUDA (Biological) $72.93
- INTERSTIM (Device) $64.78
- XIAFLEX (Biological) $59.08
- XYOSTED (Drug) $51.90
- NOCDURNA (Drug) $50.42
- Xtandi (Drug) $47.38
- AVEED (Biological) $46.77
- ORGOVYX (Drug) $37.77
- GEMTESA (Drug) $33.42
- LUPRON DEPOT (Drug) $28.51
- AQUABEAM SYSTEM (Device) $22.78
- JYNARQUE (Drug) $15.88
- Axonics (Device) $15.77
- Natesto (Drug) $11.63
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.